COMT and betaAR Polymorphism and Development of Painful TMD
COMT和betaAR多态性与疼痛TMD的发展
基本信息
- 批准号:7578234
- 负责人:
- 金额:$ 33.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-05 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AR geneAdrenergic ReceptorAffectAllelesBiochemicalBiologicalBiological ProcessBlood CellsBlood specimenCase-Control StudiesCatabolismCatalogingCatalogsCatecholaminesCell Culture TechniquesClinical DataCodeCohort StudiesDNADataData SetDevelopmentDiagnosisDopamineEnzymesEpinephrineFemaleFrequenciesFunctional disorderGene StructureGenesGeneticGenetic PolymorphismGenetic TranscriptionGenotypeHaplotypesHeatingHumanIndividualLeadLinkMeasuresMechanicsMenstrual cycleMetabolismMethyltransferaseMethyltransferase GeneMolecularNeuraxisNorepinephrineNucleotidesOpioid Receptor BindingOrofacial PainPainPain-FreeParticipantPatientsPerceptionPharmacogeneticsPhenotypePopulationPropertyProspective StudiesProteinsReceptor GeneRecruitment ActivityRegulationRelative (related person)ResearchResearch PersonnelRiskRisk FactorsSeriesSeverity of illnessSigns and SymptomsSingle Nucleotide PolymorphismStimulusSumTemporomandibular Joint DisordersTranscriptTranslationsVariantbasecase controlcohortdisorder controlgenetic risk factorgenetic varianthuman femalein vitro activitynovelprogramsprospectivereceptorreceptor densityrisk perception
项目摘要
DESCRIPTION: (provided by the applicant) Painful temporomandibular disorder (TMD) is a very common orofacial pain condition that affects a large proportion of the human population with a strong bias towards females. The risk of developing TMD and the severity of the disease are associated with a generalized sensitivity to pain. In preliminary studies, we found that specific genetic variants (haplotypes) that code for catecholamine-O-methyltransferase (COMT), an enzyme regulating catecholamine levels, and Beta2-adrenergic receptor (Beta2-AR), a receptor target for epinephrine, are associated with human pain perception and the risk of developing a myogenous TMD. We propose to extend our preliminary assessments of selected SNPs by identifying and functionally characterizing the full haplotype structure of the genes that code for COMT and Beta2-AR. We will identify individual single nucleotide polymorphisms (SNPs) and haplotypes that are associated with pain perception, menstrual cycle related somatic complaints, and the risk of developing myogenous TMD. In order to accomplish this, we will conduct a case-control study on 200 female TMD patients and 200 female control patients. We will also conduct a series of biochemical and molecular biological studies that will examine the mechanisms by which polymorphisms in COMT and Beta2-AR genes affect the biological functions of the respective coded proteins. By elucidating the genetic factors that influence human pain perception, these studies will contribute to our understanding of the pathophysiology underlying myogenous TMD and may lead to new pharmacogenetic approaches to the diagnosis and treatment of TMD patients.
描述:(由申请人提供)疼痛的颞下颌疾病(TMD)是一种非常常见的口面疼痛状况,影响了大部分人口,对女性有很大的偏见。发展TMD的风险和疾病的严重程度与对疼痛的普遍敏感性有关。在初步研究中,我们发现特定的遗传变异(单倍型),这些特定的儿茶酚胺-O-甲基转移酶(COMT),一种调节儿茶酚胺水平的酶以及Beta2-肾上腺素受体(beta2-ar)的酶(beta2-ar),AN与epinephrine的受体靶标相关,与人类疼痛相关联,并且与人类疼痛相关。我们建议通过识别和功能表征COMT和BETA2-AR代码的基因的完整单倍型结构来扩展对选定SNP的初步评估。我们将确定与疼痛感,与月经周期相关的躯体抱怨以及发展肌H的风险相关的单个单核苷酸多态性(SNP)和单倍型。为了实现这一目标,我们将对200名女性TMD患者和200名女性对照患者进行病例对照研究。我们还将进行一系列的生化和分子生物学研究,这些研究将研究COMT和BETA2-AR基因中的多态性影响相应编码蛋白的生物学功能的机制。通过阐明影响人类疼痛感知的遗传因素,这些研究将有助于我们对肌源性TMD潜在的病理生理学的理解,并可能导致新的药物遗传学方法来诊断和治疗TMD患者。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase.
- DOI:10.1186/1744-8069-5-13
- 发表时间:2009-03-16
- 期刊:
- 影响因子:3.3
- 作者:Tchivileva IE;Nackley AG;Qian L;Wentworth S;Conrad M;Diatchenko LB
- 通讯作者:Diatchenko LB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LUDA DIATCHENKO其他文献
LUDA DIATCHENKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LUDA DIATCHENKO', 18)}}的其他基金
Biomedical Researcher Development Program in TMJD and Orofacial Pain
颞下颌关节紊乱病和口面部疼痛生物医学研究员发展计划
- 批准号:
8527757 - 财政年份:2012
- 资助金额:
$ 33.06万 - 项目类别:
Biomedical Researcher Development Program in TMJD and Orofacial Pain
颞下颌关节紊乱病和口面部疼痛生物医学研究员发展计划
- 批准号:
8353144 - 财政年份:2012
- 资助金额:
$ 33.06万 - 项目类别:
Genetic and Psychosocial Influences on Transition to Chronic TMD and Related Pain
遗传和社会心理对慢性 TMD 及相关疼痛的影响
- 批准号:
8713244 - 财政年份:2005
- 资助金额:
$ 33.06万 - 项目类别:
Genetic and Psychosocial Influences on Transition to Chronic TMD and Related Pain
遗传和社会心理对慢性 TMD 及相关疼痛的影响
- 批准号:
8525386 - 财政年份:2005
- 资助金额:
$ 33.06万 - 项目类别:
COMT and betaAR Polymorphism and Development of Painful*
COMT 和 betaAR 多态性与 Painful* 的发展
- 批准号:
7049499 - 财政年份:2005
- 资助金额:
$ 33.06万 - 项目类别:
COMT and betaAR Polymorphism and Development of Painful TMD
COMT和betaAR多态性与痛苦TMD的发展
- 批准号:
7365142 - 财政年份:2005
- 资助金额:
$ 33.06万 - 项目类别:
Genetic and Psychosocial Influences on Transition to Chronic TMD and Related Pain
遗传和社会心理对慢性 TMD 及相关疼痛的影响
- 批准号:
8391918 - 财政年份:2005
- 资助金额:
$ 33.06万 - 项目类别:
相似国自然基金
β2肾上腺素能受体基因多态性Arg16Gly影响慢性心衰预后及 β受体阻滞剂疗效的机制研究
- 批准号:81800356
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
抗β1/2肾上腺素能受体自身抗体表达增强对心房颤动的影响及机制研究
- 批准号:81660053
- 批准年份:2016
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
肾上腺素能受体SNPs及PWV、CBP对射血分数保留心衰的发病及药物敏感性的影响
- 批准号:81471402
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
肾上腺素联合艾司洛尔对复苏后心肌β-肾上腺素能受体信号通路及线粒体的影响
- 批准号:81372025
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
低切应力通过β1AR-mTOR信号转导通路影响内皮细胞eNOS功能的分子机制研究
- 批准号:81270191
- 批准年份:2012
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Identifying the role of interferon and interferon-regulated chemokines in stress-induced immunosuppression in triple negative breast cancer
确定干扰素和干扰素调节的趋化因子在三阴性乳腺癌应激诱导的免疫抑制中的作用
- 批准号:
10727051 - 财政年份:2023
- 资助金额:
$ 33.06万 - 项目类别:
Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol
用 R-卡维地洛预防紫外线引起的免疫抑制和皮肤癌
- 批准号:
10653137 - 财政年份:2022
- 资助金额:
$ 33.06万 - 项目类别:
Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol
用 R-卡维地洛预防紫外线引起的免疫抑制和皮肤癌
- 批准号:
10418263 - 财政年份:2022
- 资助金额:
$ 33.06万 - 项目类别:
Novel role of beta2-adrenergic receptor signaling in vBNST CRF-mediated stress-induced ethanol intake
β2-肾上腺素能受体信号在 vBNST CRF 介导的应激诱导的乙醇摄入中的新作用
- 批准号:
10226256 - 财政年份:2019
- 资助金额:
$ 33.06万 - 项目类别:
Novel role of beta2-adrenergic receptor signaling in vBNST CRF-mediated stress-induced ethanol intake
β2-肾上腺素能受体信号在 vBNST CRF 介导的应激诱导的乙醇摄入中的新作用
- 批准号:
10005021 - 财政年份:2019
- 资助金额:
$ 33.06万 - 项目类别: